Biocon Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA1,9072,183
EBIT1,2051,258
Earning Per Share65
Expenses5,4536,214
Net Profit916979
Net Profit Margin1312
Operating Profit Margin2727
Profit Before Tax1,1471,190
Dividends Per Share01
Operation Revenue7,3608,397

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Biocon is 2,183 as of 3/4/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20092009200920092017
Operating Activities95959595640
Investing Activities-232-232-232-232-499
Financing Activities137137137137-178
Others00000
Net Cash Flow-0-0-0-0-36

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Biocon is 640 as of 3/4/2024